Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Smith

Showing results (31-40 of 200) with videos related to

Pageof 20
Sort By:
International Journal of Cancer|December 27, 2017
The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivoLu Dai, Charles D Smith, Maryam Foroozesh, et al.
Methods (San Diego, Calif.)|October 3, 2006
In vitro and cellular assays for palmitoyl acyltransferases using fluorescent lipidated peptidesCharles E Ducker, Jeremiah M Draper, Zuping Xia, et al.
American Journal of Alzheimer'S Disease and Other Dementias|October 23, 2003
Secondary dementia caregiving and its consequencesJoseph E Gaugler, Marta Mendiondo, Charles D Smith, et al.
Oncology Research|October 14, 2003
Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008Brian D Lee, Kevin J French, Yan Zhuang, et al.
Magnetic Resonance Imaging|January 10, 2012
Partial least squares for discrimination in fMRI dataAnders H Andersen, William S Rayens, Yushu Liu, et al.
Human Brain Mapping|January 12, 2010
Functional response in ventral temporal cortex differentiates mild cognitive impairment from normal agingBrian T Gold, Yang Jiang, Greg A Jicha, et al.
Plos One|September 13, 2012
Characterization of isoenzyme-selective inhibitors of human sphingosine kinasesPeng Gao, Yuri K Peterson, Ryan A Smith, et al.
Journal of Alzheimer'S Disease : JAD|March 31, 2012
Multimodal imaging evidence for axonal and myelin deterioration in amnestic mild cognitive impairmentBrian T Gold, Yang Jiang, David K Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor developmentMelissa A Tran, Charles D Smith, Mark Kester, et al.
Journal of Neuro-Oncology|June 28, 2005
An unusual complication of cancer treatment for acute lymphoblastic leukemiaRosario Maria S Riel-Romero, Robert J Baumann, Charles D Smith
Pageof 20

Showing results (31-40 of 200) with videos related to

Sort By:
Pageof 20
International Journal of Cancer|December 27, 2017
The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivoLu Dai, Charles D Smith, Maryam Foroozesh, et al.
Methods (San Diego, Calif.)|October 3, 2006
In vitro and cellular assays for palmitoyl acyltransferases using fluorescent lipidated peptidesCharles E Ducker, Jeremiah M Draper, Zuping Xia, et al.
American Journal of Alzheimer'S Disease and Other Dementias|October 23, 2003
Secondary dementia caregiving and its consequencesJoseph E Gaugler, Marta Mendiondo, Charles D Smith, et al.
Oncology Research|October 14, 2003
Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008Brian D Lee, Kevin J French, Yan Zhuang, et al.
Magnetic Resonance Imaging|January 10, 2012
Partial least squares for discrimination in fMRI dataAnders H Andersen, William S Rayens, Yushu Liu, et al.
Human Brain Mapping|January 12, 2010
Functional response in ventral temporal cortex differentiates mild cognitive impairment from normal agingBrian T Gold, Yang Jiang, Greg A Jicha, et al.
Plos One|September 13, 2012
Characterization of isoenzyme-selective inhibitors of human sphingosine kinasesPeng Gao, Yuri K Peterson, Ryan A Smith, et al.
Journal of Alzheimer'S Disease : JAD|March 31, 2012
Multimodal imaging evidence for axonal and myelin deterioration in amnestic mild cognitive impairmentBrian T Gold, Yang Jiang, David K Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor developmentMelissa A Tran, Charles D Smith, Mark Kester, et al.
Journal of Neuro-Oncology|June 28, 2005
An unusual complication of cancer treatment for acute lymphoblastic leukemiaRosario Maria S Riel-Romero, Robert J Baumann, Charles D Smith
Pageof 20